Structure Therapeutics (GPCR) Interest & Investment Income (2022 - 2026)
Quarterly Interest & Investment Income rose 42.03% to $13.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $39.9 million through Mar 2026, up 0.8% year-over-year, with the annual reading at $35.9 million for FY2025, 0.39% changed from the prior year.
Structure Therapeutics' Interest & Investment Income history spans 5 years, with the latest figure at $13.6 million for Q1 2026.
- Interest & Investment Income came in at $13.6 million for Q1 2026, up from $9.2 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $13.6 million in Q1 2026 to a low of -$69000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $6.2 million (2023), against an average of $5.9 million.
- Year-over-year, Interest & Investment Income soared 3617.11% in 2023 and then plummeted 31.53% in 2025.
- Structure Therapeutics' Interest & Investment Income stood at $901000.0 in 2022, then soared by 585.79% to $6.2 million in 2023, then skyrocketed by 73.46% to $10.7 million in 2024, then fell by 14.3% to $9.2 million in 2025, then surged by 48.08% to $13.6 million in 2026.
- Per Business Quant, the three most recent readings for GPCR's Interest & Investment Income are $13.6 million (Q1 2026), $9.2 million (Q4 2025), and $8.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Structure Therapeutics | 8.43 Bn | 8.43 Bn | - | 13.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.60 Mn |
| Dec 31, 2025 | 9.19 Mn |
| Sep 30, 2025 | 8.18 Mn |
| Jun 30, 2025 | 8.93 Mn |
| Mar 31, 2025 | 9.58 Mn |
| Dec 31, 2024 | 10.72 Mn |
| Sep 30, 2024 | 11.95 Mn |
| Jun 30, 2024 | 7.34 Mn |
| Mar 31, 2024 | 6.01 Mn |
| Dec 31, 2023 | 6.18 Mn |
| Sep 30, 2023 | 2.69 Mn |
| Jun 30, 2023 | 2.83 Mn |
| Mar 31, 2023 | 1.70 Mn |
| Dec 31, 2022 | 901,000.00 |
| Sep 30, 2022 | 349,000.00 |
| Jun 30, 2022 | 76,000.00 |
| Mar 31, 2022 | -69,000.00 |